Clover Biopharmaceuticals, Current Assets

Clover Biopharmaceuticals, (2197.HK) currently reports a current assets of $130M as of June 2026. That compares with $460M in the prior-year period — down 71.5% year over year. Use the charts on this page to explore Clover Biopharmaceuticals,'s current assets history and peer comparisons.

Clover Biopharmaceuticals,'s current assets decreased from $460M to $130M — a 71.5% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Clover Biopharmaceuticals, reported $130M in current assets as of June 2026. That compares with $460M in the prior-year period — down 71.5% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current assets of $130M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Clover Biopharmaceuticals,, and consider following 2197.HK for alerts when major investors trade the stock.

Clover Biopharmaceuticals, is classified in the Healthcare sector. On current assets, it currently shows $130M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing 2197.HK with unrelated industries.